Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial - Ramacciotti, Eduardo; Agati, Leandro Barile; Calderaro, Daniela; Aguiar, Valéria Cristina Resende; Spyropoulos, Alex C; Oliveira, Caroline Candida Carvalho de; Santos, Jessica Lins dos; Volpiani, Giuliano Giova; Sobreira, Marcone Lima; Joviliano, Edwaldo Edner; Bohatch Júnior, Milton Sérgio; Fonseca, Benedito Antonio Lopes da; et al. (The Lancet, 2022)